Development of a radiomic classification model RadMenGR for discriminating Grade 1 and Grade 2 intracranial meningioma
https://doi.org/10.29001/2073-8552-2026-41-1-213-220
Abstract
Background. Preoperative differentional diagnosis of meningioma grade remains challenging with routine brain magnetic resonance imaging (MRI). The lack of reliable non-invasive tools limits the potential for early risk stratification and treatment planning.
Aim: To develop an interpretable classification radiomic model RadMenGR for predicting meningioma grade (Grade I or Grade II) based on contrast-enhanced T1-weighted images.
Material and Methods. This retrospective single-center study was conducted using the open-source anonymized dataset MeningiomaSEG-CLASS. 95 patients were included in the analysis (53 with Grade 1 and 42 with Grade 2 tumors). 105 radiomic features were extracted from manually segmented MR images using PyRadiomics. Classification was performed with a Naive Bayes algorithm following feature discretization using the Entropy / MDL method. Diagnostic performance was assessed using the area under the curve (AUC), sensitivity, specificity, and accuracy. Bootstrap analysis with 10,000 iterations and a 95% confidence interval was used for validation.
Results. On the validation cohort (n = 46), the ROC-AUC was 0.805 (95% CI: 0.671–0.915). The lower bound of the 95% CI for the AUC exceeded the value under the null hypothesis (AUC = 0.63), confirming the statistical significance of the results (p < 0.05). Conclusion. This study developed an interpretable radiomic classification model for the differential diagnosis of Grade 1 and Grade 2 meningiomas. The application of a Naive Bayes algorithm to features extracted from contrast-enhanced T1-weighted images and transformed using a discretization method enabled the achievement of a significant level of diagnostic accuracy. However, the width of the confidence interval points to a lack of model robustness, necessitating validation on an independent cohort.
Keywords
About the Authors
Yu. A. VasilevRussian Federation
Yuri A. Vasilev - Dr. Sci. (Med.), Medical Director, Moscow Center for Diagnostics and Telemedicine.
24 building 1, Petrovka str., Moscow, 127051
A. K. Karpenko
Russian Federation
Anastasia K. Karpenko - Student, Sechenov University.
8 build. 2, Trubetskaya str., Moscow, 119048
M. O. Romanenko
Russian Federation
Maria O. Romanenko - Junior Research Scientist, Radiology Research Section, Moscow Center for Diagnostics and Telemedicine.
24 building 1, Petrovka str., Moscow, 127051
O. V. Omelyanskaya
Russian Federation
Olga V. Omelyanskaya - Deputy Director of Prospective Development, Moscow Center for Diagnostics and Telemedicine.
24 building 1, Petrovka str., Moscow, 127051
A. V. Vladzymyrskyy
Russian Federation
Anton V. Vladzymyrskyy - Dr. Sci. (Med.), Professor, Deputy Director of R&D, Moscow Center for Diagnostics and Telemedicine.
24 building 1, Petrovka str., Moscow, 127051
I. A. Blokhin
Russian Federation
Ivan A. Blokhin - Cand. Sci. (Med.), Head of Radiology Research Section, Moscow Center for Diagnostics and Telemedicine.
24 building 1, Petrovka str., Moscow, 127051
References
1. Yarabarla V., Mylarapu A., Han T.J., McGovern S.L., Raza S.M., Beckham T.H. Intracranial meningiomas: an update of the 2021 World Health Organization classifications and review of management with a focus on radiation therapy. Front. Oncol. 2023;13:1137849. https://doi.org/10.3389/fonc.2023.1137849
2. Ostrom Q.T., Price M., Neff C., Cioffi G., Waite K.A., Kruchko C. et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016–2020. Neuro. Oncol. 2023;25:iv1–99. https://doi.org/10.1093/neuonc/noad149
3. Goldbrunner R., Minniti G., Preusser M., Jenkinson M.D., Sallabanda K., Houdart E. et al. EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol. 2016;17:e383–e391. https://doi.org/10.1016/S1470-2045(16)30321-7
4. Upreti T., Dube S., Pareek V., Sinha N., Shankar J. Meningioma grading via diagnostic imaging: A systematic review and meta-analysis. Neuroradiology. 2024;66:1301–1310. https://doi.org/10.1007/s00234-024-03404-0
5. Brugada-Bellsolà F., Teixidor Rodríguez P., Rodríguez-Hernández A., Garcia-Armengol R., Tardáguila M., González-Crespo A. Growth prediction in asymptomatic meningiomas: the utility of the AIMSS score. Acta Neurochir. (Wien.). 2019;161:2233–2240. https://doi.org/10.1007/s00701-019-04056-3
6. Vasilev Y.A., Vladzymyrskyy A.V. Artificial intelligence in radiology: Per Aspera Ad Astra. М: Izdatelskie Resheneiya; 2025:491. (In Russ.). ISBN 978-5-0067-5622-9.
7. Lee T., Lee J.H., Yoon S.H., Park S.H., Kim H. Availability and transparency of artificial intelligence models in radiology: a meta-research study. Eur. Radiol. 2025. https://doi.org/10.1007/s00330-025-11492-6
8. Vassantachart A., Cao Y., Shen Z., Cheng K., Gribble M., Ye J.C. et al. A repository of grade 1 and 2 meningioma MRIs in a public dataset for radiomics reproducibility tests. Med. Phys. 2024;51(3):2334–2344. https://doi.org/10.1002/mp.16763
9. Blokhin I.A., Kodenko M.R., Shumskaya Yu.F., Goncgar A.P., Reshetnikov R.V. Hypothesis testing using R. Digital Diagnostics. 2023;4(2):238−247. (In Russ.). https://doi.org/10.17816/DD121368
10. Park J.H., Quang L.T., Yoon W., Baek B.H., Park I., Kim S.K. Predicting histologic grade of meningiomas using a combined model of radiomic and clinical imaging features from preoperative MRI. Biomedicines. 2023;11:3268. https://doi.org/10.3390/biomedicines11123268
11. Buerki R.A., Horbinski C.M., Kruser T., Horowitz P.M., James C.D., Lukas R.V. An overview of meningiomas. Future Oncol. 2018;14:2161–2177. https://doi.org/10.2217/fon-2018-0006
12. Patel R.V., Yao S., Huang R.Y., Bi W.L. Application of radiomics to meningiomas: A systematic review. Neuro. Oncol. 2023;25:1166–1176. https://doi.org/10.1093/neuonc/noad028
13. Woznicki P., Laqua F.C., Al-Haj A., Bley T., Baeßler B. Addressing challenges in radiomics research: systematic review and repository of open-access cancer imaging datasets. Insights Imaging. 2023;14:216. https://doi.org/10.1186/s13244-023-01556-w
14. Hale A.T., Stonko D.P., Wang L., Strother M.K., Chambless L.B. Machine learning analyses can differentiate meningioma grade by features on magnetic resonance imaging. Neurosurg. Focus. 2018;45:E4. https://doi.org/10.3171/2018.8.FOCUS18191
15. Santhosh G. Medical Image Classification using Interesting Pruning and Machine Learning Algorithm. International Journal of Intelligent Systems and Applications in Engineering. 2024;12(21s):4260–4272. URL: https://mail.ijisae.org/index.php/IJISAE/article/view/6284 (23.01.2026).
16. Yan P.F., Yan L., Hu T.T., Xiao D.D., Zhang Z., Zhao H.Y. et al. The potential value of preoperative MRI texture and shape analysis in grading meningiomas: a preliminary investigation. Transl. Oncol. 2017;10:570–577. https://doi.org/10.1016/j.tranon.2017.04.006
17. Korte J.C., Cardenas C., Hardcastle N., Kron T., Wang J., Bahig H. et al. Radiomics feature stability of open-source software evaluated on apparent diffusion coefficient maps in head and neck cancer. Sci. Rep. 2021;11:17633. https://doi.org/10.1038/s41598-021-96600-4
18. Method of monitoring technical condition of magnetic resonance imaging scanner using clinical images of brain. Patent RU 2811031 C1. Vasilev Yu.A., Semenov E.S., Akhmad E.S., Petryajkin A.V., Smorchkova A.K., Kudryavtsev N.D. et al. Date of registration: 10.01.2024. (In Russ.). URL: https://www.elibrary.ru/item.asp?id=59921654 (23.01.2026).
19. Akhmad E.S., Semenov D.S., Sergunova K.A., Petryajkin A.V., Andreychenko A.E., Smirnov A.V. et al. Methodology of monitoring parameters and characteristics of magnetic resonance imaging scanner during operation. of monitoring of Methodical recommendations. Series «The best practices in radiation and instrumental diagnostics». M: Moscow Center for Diagnostics and Telemedicine; 2022:80. (In Russ.).
Review
For citations:
Vasilev Yu.A., Karpenko A.K., Romanenko M.O., Omelyanskaya O.V., Vladzymyrskyy A.V., Blokhin I.A. Development of a radiomic classification model RadMenGR for discriminating Grade 1 and Grade 2 intracranial meningioma. Siberian Journal of Clinical and Experimental Medicine. 2026;41(1):213-220. (In Russ.) https://doi.org/10.29001/2073-8552-2026-41-1-213-220
JATS XML


.png)
























